{"entity":{"type":"insider","cik":"0001771499","url":"/insider/0001771499","json_url":"/insider/0001771499.json","name":"HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":5,"first":"2019-05-22","last":"2021-03-17","span_basis":"filed_date"},"name_variants":[{"name":"HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC","source":"filing","n_filings":5,"first_seen":"2019-05-22","last_seen":"2021-03-17"}],"transactions":[{"id":5277338,"accession":"0000902664-21-001964","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-21-001964","line_url":"/filing/0000902664-21-001964","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"LUCAS KENAN; HARBERT RAYMOND J; HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY FUND GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; Harbert Discovery Fund, LP; BRYANT JOHN F.","owner_display_name":"LUCAS KENAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":4.646333333333334,"price_display":"4.65","price_state":"stated","total_value":1393900.0,"total_display":"1,393,900.00","total_whole":"1,393,900","shares_owned_after":5275913.0,"shares_owned_after_display":"5,275,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":5277336,"accession":"0000902664-21-001964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-21-001964","line_url":"/filing/0000902664-21-001964","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"LUCAS KENAN; HARBERT RAYMOND J; HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY FUND GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; Harbert Discovery Fund, LP; BRYANT JOHN F.","owner_display_name":"LUCAS KENAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, $0.01 par value (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144768.0,"shares_display":"144,768","price_per_share":4.827309902740938,"price_display":"4.83","price_state":"stated","total_value":698840.0,"total_display":"698,840.00","total_whole":"698,840","shares_owned_after":5520681.0,"shares_owned_after_display":"5,520,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":7992415,"accession":"0000902664-19-003504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-003504","line_url":"/filing/0000902664-19-003504#line-2","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"LUCAS KENAN; Harbert Discovery Fund, LP; HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY FUND GP, LLC; HARBERT RAYMOND J; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; BRYANT JOHN F.","owner_display_name":"LUCAS KENAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9700.0,"shares_display":"9,700","price_per_share":3.11,"price_display":"3.11","price_state":"stated","total_value":30167.0,"total_display":"30,167.00","total_whole":"30,167","shares_owned_after":5620681.0,"shares_owned_after_display":"5,620,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":7992412,"accession":"0000902664-19-003504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-003504","line_url":"/filing/0000902664-19-003504#line-1","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"LUCAS KENAN; Harbert Discovery Fund, LP; HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY FUND GP, LLC; HARBERT RAYMOND J; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; BRYANT JOHN F.","owner_display_name":"LUCAS KENAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22800.0,"shares_display":"22,800","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":69768.0,"total_display":"69,768.00","total_whole":"69,768","shares_owned_after":5610981.0,"shares_owned_after_display":"5,610,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-20","scope":"insider"},{"id":8144149,"accession":"0000902664-19-003140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-003140","line_url":"/filing/0000902664-19-003140#line-2","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; Harbert Discovery Fund, LP; HARBERT MANAGEMENT CORP; HARBERT DISCOVERY FUND GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; BRYANT JOHN F.; HARBERT RAYMOND J; HARBERT FUND ADVISORS, INC.; LUCAS KENAN","owner_display_name":"HARBERT DISCOVERY CO-INVESTMENT FUND I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":409200.0,"shares_display":"409,200","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":1493580.0,"total_display":"1,493,580.00","total_whole":"1,493,580","shares_owned_after":5588181.0,"shares_owned_after_display":"5,588,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-23","filed_date":"2019-07-24","scope":"insider"},{"id":8144147,"accession":"0000902664-19-003140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-003140","line_url":"/filing/0000902664-19-003140#line-1","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; Harbert Discovery Fund, LP; HARBERT MANAGEMENT CORP; HARBERT DISCOVERY FUND GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; BRYANT JOHN F.; HARBERT RAYMOND J; HARBERT FUND ADVISORS, INC.; LUCAS KENAN","owner_display_name":"HARBERT DISCOVERY CO-INVESTMENT FUND I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9644.0,"shares_display":"9,644","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":35104.16,"total_display":"35,104.16","total_whole":"35,104","shares_owned_after":5178981.0,"shares_owned_after_display":"5,178,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-24","scope":"insider"},{"id":8024948,"accession":"0000902664-19-002561","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-19-002561","line_url":"/filing/0000902664-19-002561#line-4","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY FUND GP, LLC; HARBERT RAYMOND J; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; Harbert Discovery Fund, LP; BRYANT JOHN F.; LUCAS KENAN","owner_display_name":"HARBERT FUND ADVISORS, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19391.0,"shares_display":"19,391","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":59530.37,"total_display":"59,530.37","total_whole":"59,530","shares_owned_after":5169337.0,"shares_owned_after_display":"5,169,337","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-05-30","scope":"insider"},{"id":8024945,"accession":"0000902664-19-002561","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-19-002561","line_url":"/filing/0000902664-19-002561#line-3","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY FUND GP, LLC; HARBERT RAYMOND J; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; Harbert Discovery Fund, LP; BRYANT JOHN F.; LUCAS KENAN","owner_display_name":"HARBERT FUND ADVISORS, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19050.0,"shares_display":"19,050","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":58674.0,"total_display":"58,674.00","total_whole":"58,674","shares_owned_after":5149946.0,"shares_owned_after_display":"5,149,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":8024943,"accession":"0000902664-19-002561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-002561","line_url":"/filing/0000902664-19-002561","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT FUND ADVISORS, INC.; HARBERT DISCOVERY FUND GP, LLC; HARBERT RAYMOND J; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT MANAGEMENT CORP; Harbert Discovery Fund, LP; BRYANT JOHN F.; LUCAS KENAN","owner_display_name":"HARBERT FUND ADVISORS, INC.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, $0.01 par value (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63677.0,"shares_display":"63,677","price_per_share":3.0914085148483754,"price_display":"3.09","price_state":"stated","total_value":196851.62,"total_display":"196,851.62","total_whole":"196,852","shares_owned_after":5117219.0,"shares_owned_after_display":"5,117,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider","n_lines":2},{"id":7831437,"accession":"0000902664-19-002480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-002480","line_url":"/filing/0000902664-19-002480#line-1","is_derivative":false,"issuer_cik":"0000316253","issuer_name":"ENZO BIOCHEM INC","issuer_ticker":"ENZ","issuer_name_source":null,"issuer_url":"/issuer/0000316253","owner_cik":null,"owner_name":"HARBERT MANAGEMENT CORP; HARBERT RAYMOND J; BRYANT JOHN F.; HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC; HARBERT DISCOVERY CO-INVESTMENT FUND I, LP; HARBERT FUND ADVISORS, INC.; Harbert Discovery Fund, LP; HARBERT DISCOVERY FUND GP, LLC; LUCAS KENAN","owner_display_name":"HARBERT MANAGEMENT CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14132.0,"shares_display":"14,132","price_per_share":3.61,"price_display":"3.61","price_state":"stated","total_value":51016.52,"total_display":"51,016.52","total_whole":"51,017","shares_owned_after":5067219.0,"shares_owned_after_display":"5,067,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000316253","name":"ENZO BIOCHEM INC","url":"/issuer/0000316253","role":"Ten percent owner","n_filings":5,"first_seen":"2019-05-22","last_seen":"2021-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001771499","retrieved_at":"2026-08-23T01:53:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}